| Product Code: ETC13306957 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Cell Gene Therapy CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Cell Gene Therapy CDMO Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Cell Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Cell Gene Therapy CDMO Market - Industry Life Cycle |
3.4 Africa Cell Gene Therapy CDMO Market - Porter's Five Forces |
3.5 Africa Cell Gene Therapy CDMO Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Cell Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Africa Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.8 Africa Cell Gene Therapy CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Africa Cell Gene Therapy CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Africa Cell Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Cell Gene Therapy CDMO Market Trends |
6 Africa Cell Gene Therapy CDMO Market, 2021 - 2031 |
6.1 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Viral Vector Manufacturing, 2021 - 2031 |
6.1.3 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Plasmid DNA Manufacturing, 2021 - 2031 |
6.1.4 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Cell Therapy Manufacturing, 2021 - 2031 |
6.1.5 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Cryopreservation Services, 2020 - 2028 |
6.2 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Lentiviral Vector Technology, 2021 - 2031 |
6.2.3 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Plasmid-Based Gene Delivery, 2021 - 2031 |
6.2.4 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By CAR-T Cell Expansion Technology, 2021 - 2031 |
6.2.5 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Controlled-Rate Freezing, 2021 - 2031 |
6.3 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031 |
6.3.3 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.4 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.3.5 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Cell and Gene Therapy Developers, 2021 - 2031 |
6.4 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Gene Delivery for Cell Therapy, 2021 - 2031 |
6.4.3 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Preclinical and Clinical Studies, 2021 - 2031 |
6.4.4 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Oncology and Rare Diseases Treatment, 2020 - 2028 |
6.4.5 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Transport of Cell Therapies, 2020 - 2028 |
7 Africa Cell Gene Therapy CDMO Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 South Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Egypt Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Nigeria Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.4 Rest of Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 Africa Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
7.3.1 South Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.2 Egypt Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.3 Nigeria Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.4 Rest of Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 South Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Egypt Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Nigeria Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Rest of Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 South Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Egypt Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Nigeria Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.4 Rest of Africa Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Africa Cell Gene Therapy CDMO Market Key Performance Indicators |
9 Africa Cell Gene Therapy CDMO Market - Export/Import By Countries Assessment |
10 Africa Cell Gene Therapy CDMO Market - Opportunity Assessment |
10.1 Africa Cell Gene Therapy CDMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Cell Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 Africa Cell Gene Therapy CDMO Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.4 Africa Cell Gene Therapy CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Africa Cell Gene Therapy CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
11 Africa Cell Gene Therapy CDMO Market - Competitive Landscape |
11.1 Africa Cell Gene Therapy CDMO Market Revenue Share, By Companies, 2022 |
11.2 Africa Cell Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here